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The correlation between neutralizing antibodies and resistance to encephalitis 
virus  infections  cannot  as  yet be  stated  in  general  terms.  Each  individual 
virus seems endowed with  its own  characteristics in  a  particular host.  The 
subject has become of such practical importance, however, especially in evalu- 
ating vaccines, that in spite of excellent work already reported, further studies 
seemed  indicated.  Consequently  experiments  were  carried  out  in  mice  to 
compare  resistance to  a  test  infection  with  level of  (a)  neutralizing and  (b) 
complement-fixing antibodies in the blood at various intervals following vac- 
cination. 
Materials and Methods 
Virus.--The St. Louis encephalitis virus used in our work is the Strain B 33 which 
was isolated in 1933; it had been propagated in our laboratory for several years, then 
sent to Dr. G. O. Broun in St. Louis in 1937, and in 1938 the strain was sent back to us. 
The strain of W.E.E. virus employed in this study is one (McMillan) which was iso- 
lated by us (1) from a fatal case in Canada in 1941. 
The viruses are maintained in our laboratory in the form of a  10 per cent mouse 
brain emulsion stored in dry ice at  -76°C., thus reducing the number of mouse pas- 
sages to a minimum.  The St. Louis virus had had a considerable number of passages 
prior to 1940, when it was propagated by alternating mouse intracerebral passage with 
storage in glycerine.  The W.E.E. strain used in the tests had had only four or five 
passages. 
Mice.--All mice employed in  this investigation were of the W-Swiss strain  (2). 
Special care was taken to secure large groups of animals of similar age and weight in 
order to insure uniformity of results.  The mice used for vaccination in the experiment 
with W.E.E. virus were from 70 to 90 days old at the time of vaccination and weighed 
from 23 to 28 gm.  Those used for the tests with the St. Louis virus were from 50 to 
70 days of age when the experiment was started and their weights varied between 20 
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and 24 gm.  Mice employed for titrations of virus or in the neutralization tests were 
younger, from 22 to 30 days old, and their weights were from 11 to 13 gin. 
A group of mice needs special mention here, namely, those used for intraperitoneal 
neutralization tests with W.E.E. virus.  As shown by Olitsky and Harford (3), very 
young animals are necessary for that purpose.  We used mice between 14 and 17 
days of age.  However, the supply of such mice was rather limited and in some cases 
they were not as uniform in size as desired. 
Immu.~ization and Vaccines.--The immunization  of mice was carried out either with 
live virus or with inactivated virus.  For immunizing  with live virus we proceeded 
as follows:  Three mice were infected intracerebrally with the particular virus in 10  -~ 
dilution.  When prostrate, about 40 hours later in the case of W.E.E. virus and 3 to 4 
days in the case of St. Louis virus, their brains were removed, ground up in a mortar, 
and emulsified in a sufficient amount of buffered distilled water to yield a  10 per cent 
suspension.  This suspension  was centrifuged at 2,000 R.P.x~. for 10 minutes, the super- 
natant pipetted off and further diluted in the same diluent to the required strength, 
and then used for vaccination.  The amount of active virus present in the dilutions 
was determined by intracerebral titration in young mice.  The titer of the St. Louis 
virus was 10  -7 to 10  -8 and that of the W.E.E. virus 10-s to 10  -9.  Mice were vac- 
cinated by means of one subcutaneous injection of 0.5 cc. of the stated dilution. 
For immunization  with inactivated virus the following procedure was carried out. 
A batch of  thirty mice 25  days of age were inoculated intracrebrally with a  10  -s 
suspension of St. Louis virus and another similar group of mice were inoculated with 
the same dilution of W.E.E. virus.  When sick these animals were sacrificed,  their 
brains removed and weighed and emulsified with the aid of a mechanical blendor in 
sufficient amount of physiological saline to give a  l0 per cent suspension of mouse 
brain.  This suspension was then centrifuged at 2,000 R.P.,~. for 10 minutes and the 
supernatant pipetted off.  This supernatant was titrated in young mice by intra- 
cerebral inoculation, the titer being 10  -7 for the St. Louis virus and 10-8 for W.E.E. 
virus.  To the 10 per cent supernatant sufficient formalin was added to give a 0.5 
per cent concentration of formalin and this material was kept in the ice box in glass- 
stoppered flasks.  The St. Louis vaccine was tested intracerebrally for virulence 14 
days later with the result that of eight mice inoculated all survived.  The W.E.E. 
vaccine was likewise tested, 11 days later, and again all mice of eight inoculated sur- 
vived.  Both vaccines were used for vaccination, 15 and 20 days respectively after 
preparation.  Vaccination of  mice with the avirulent formolized vaccine was carried 
out in the following manner. 
St. Louis vaccine was given subcutaneously  in 0.25 cc. amounts daily for 4 consecu- 
tive days, making a total of 1 cc. of vaccine.  The W.E.E. vaccine was also adminis- 
tered subcutaneously, but in 0.2 cc. amounts daily for 3 consecutive days, making a 
total of 0.6 cc. of vaccine.  This dosage of equine encephalomyelitis  vaccine has been 
found to give good protection (4). 
Resistance Tests.--At intervals following vaccination, groups of vaccinated mice, as 
well as controls, were tested for resistance by means of an intracerebral test.  To that 
end a fresh suspension of virus was prepared by emulsifying  the brains of two or three 
mice prostrate after intracerebral infection, in a diluent consisting of 10 per cent nor- 
real rabbit serum in saline, to a concentration  of 10  -1.  This emulsion  was then centri- j.  CASALS  449 
fuged at 2,000R.P.m. for 10 minutes,  the supematant pipetted off, and further diluted in 
tenfold dilutions.  Usually  groups of four mice were infected with each dilution.  Fol- 
lowing infection the  mice were  observed  for  a  21  day  period  and  the  survivors 
discarded. 
Sera  for Neutralization  and Complement-Fixation Tests.--On the same days that mice 
were tested for resistance to infection, additional animals from the same vaccinated 
groups and from the control group were bled from the heart under ether anesthesia. 
No separate mice were kept in each group for bleeding purposes, but special care was 
taken not to bleed and infect an individual  mouse on the same day.  The bloods from 
each group were pooled, allowed to stand at room temperature, and centrifuged.  Sera 
were kept in the dry ice box until used. 
Neutralization  Tests.--Neutralization tests were carried out in the following  manner. 
A  10  -x suspension of virus was prepared by emulsifying the brain tissue of infected 
mice in diluent.  As diluent, hormone broth (pH 7.2) was used in the first two or three 
tests; in all subsequent tests 10 per cent rabbit serum in saline was employed instead 
of broth because of its more satisfactory qualities.  The original 10  -1 suspension of 
virus was centrifuged at 2,000 R.P.M. for 10 minutes and then further diluted in tenfold 
dilutions, starting with 1:50, the dilution being carried as far as necessary.  Next, 
0.3 cc. amounts of serum to be tested were put in small sterile test tubes, and 0.3 cc. 
of the proper virus dilutions  were added.  Thus the tubes contained  a constant amount 
of serum and increasing tenfold dilutions  of virus from 10-* to 10  -8 or 10  -9 as required. 
From this point on the procedure was different for the St. Louis and W.E.E. viruses. 
For the neutralization tests with St. Louis virus the serum-virus mixtures were in- 
cubated at 37°C. in a water bath for 2 hours and then injected intracerebrally into 
young mice, four animals being employed for each dilution.  With the W.E.E. virus 
the serum-virus mixtures were injected without incubation, and their virulence was 
tested in each case by two routes, the intracerebral  and intraperitoneal.  For the intra- 
cerebral neutralization tests, the serum-virus mixtures in 0.03  cc. amounts were in- 
jected intracerebrally into mice 22 to 28 days of age, three mice being employed per 
dilution.  For the intraperitoneal neutralization tests (3), the serum-virus mixtures 
were injected in 0.1 cc. amounts into 14 to 17 day old mice, two animals being em- 
ployed per dilution.  All mice were observed for 21 days and the survivors discarded. 
Interpretation  of Resistance  and  Neutralization  Tests.--The  evaluation of results 
of resistance and neutralization tests was estimated on the basis of the Reed and 
Muench method (5).  We are aware that in some of the resistance tests the spread of 
deaths is considerable and irregular, and in those cases the meaning of degree of re- 
sistance as represented by the figure arrived at may be vague.  In the tables and 
graphs we have used the notation LD-50 to indicate the 50 f)er cent lethal dose and it 
is expressed by the logarithm of the dilution,  disregarding the minus sign.  The degree 
of resistance to infection and the degree of protection given by a serum are expressed 
as resistance index and neutralization  index,  indicating the ratio between the LD-50 
of the vaccinated mice, or immune serum, and the LD-50 of the control mice, or con- 
trol serum.  With this system the resistance index and the neutralization  index of the 
controls are always 1. 
Complement-Fixation  Tests.--The determination of complement-fixing  antibodies in 
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Antigens were prepared from infected mouse brain tissue by centrifuging a 10 per cent 
suspension at 2,500 g.r.M, for 30 minutes,/reezing and thawing the supernatant four or 
five times, and then centrifuging in an angle-head centrifuge (7) at about 5,000 R.p.x,. 
for  1 hour. 
The sera were inactivated at 60°C. for 20 minutes and used in the tests in twofold 
dilutions, starting always with undiluted serum.  Two  units  of complement were 
employed.  The first phase of the reaction was incubated in the ice box at 2°C. for 18 
hours and the hemolytic system then added, consisting of 0.25 cc. of a 3 per cent sus- 
pension of packed sheep cells and 3 M.H.D. of hemolysin, also in a volume of 0.25 cc. 
The tubes were incubated for ~/~ hour at 37°C. and  then read.  The titer of a serum 
was given as the highest dilution that showed a 2 plus or better fixation.  The specific- 
ity of the reaction was absolute in all cases, as indicated by the proper controls. 
EX~PE]~  1WW.NTAL 
The first experiment was designed to compare at various intervals, over a  4 
month  period of time, the immunity and neutralizing and complement-fixing 
antibodies of mice vaccinated with virulent or non-virulent W.E.E. virus. 
Experiment •.--784  W-Swiss mice, 70 to 90 days of age and weighing from 23 to 28 
gm. at the beginning of the experiment, were employed.  These mice were distributed 
in five groups and treated as follows: group I, 199 mice, were given one subcutaneous 
injection of 0.5 cc. of virus in a dilution of 10-3; group II, 150 mice, received one sub- 
cutaneous injection of 0.5 cc. of virus in a dilution of 10-s; group III, 141 mice, received 
one subcutaneous injection of 0.5 cc. of virus in a  10  -~ dilution, and group IV, 164 
mice, were given 0.2 cc. subcutaneously of a 10 per cent formolized, avirulent vaccine, 
each day, for 3  consecutive days, the total amount  of vaccine administered being 
0.6 cc.  Finally, group V, 130 mice, were left untreated and set aside as controls. 
The choice of dilution, 10  -8, 10  -6, and 10  -~, was made with the purpose of simulating 
a severe, moderate, and mild natural infection.  As it developed, and the figures in- 
dicating the number of deaths following vaccination with live virus show, the group 
with the 10  -5 dilution had a higher percentage of deaths than was expected.  Follow- 
ing vaccination with formolized material, no mice died; some of them showed a local 
lesion at the site of inoculation of vaccine that healed in a few days.  After injection of 
live virus, deaths occurred as follows: group I  (10-3), out of 199 mice, 41 died (20 per 
cent); group II (10-~), out of 150 mice, 32 died (21 per cent); group III (10-~), out of 
141  mice, 1 died (0.7 per cent). 
Following vaccination with either live or inactivated materials, batches of mice were 
taken from each group at intervals and tested for resistance to intracerebral infection; 
these animals were also bled to test their blood for neutralizing and  complement- 
fixing antibodies.  Such tests were carried out at intervals from the first day of the 
experiment as follows: 3, 9,  16, 30, 58, and 121  days. 
The results of all the tests are given in detail in Tables I, II, and III. 
3rd Day Test.--None of the mice showed any resistance, their sera contained no com- 
plement-fixing antibodies and, with the exception of group I  (10-s), no neutralizing J.  CASALS  451 
Time 
after 
vacci- 
nation 
days 
16 
30 
58 
121 
TABLE I 
Immunity to  In~racerebral Inoculation  of W.E.E.  Virus  Following Vaccination 
Mortality of mice injected intracerebrally  Degree of immunity 
with W.E.E. virus  of vaccinated mice 
Groups of mice 
Dilution of virus injected intracerebrally  50 per cent  Protee- 
lethal  tlon 
10  "~ 10-* 10-4  10  -s  10  -e 10  ~  10  -e  10  -I  I0-10  dose  index 
10-s 
i0--~ 
i0-7 
Formolized vaccine 
Controls 
i0-3 
10-6 
i0-7 
Formolized vaccine 
Controls 
10-8 
iO--e 
10--7 
Formolized vaccine 
Controls 
i0-s 
10-6 
i0  ~ 
Formolized vaccine 
Controls 
10-a 
10s 
10-~ 
Formolized vaccine 
ControLs 
i0-s 
10  ~ 
10-7 
Formolized vaccine 
Controls 
3/3* 3/3 3/3 2/3  >8.25  ,~ 
13/3  3/3 3/3 3/3  >8.50 
3/3  3/3 3/3 3/3  >8.50  1 
3/3  3/3 3/3 3/3  >8.50 
3/3 3/3 3/3 0/3  8.50 
4/4 4/4 2/4  1/4 2/4 114  5.80  346~ 
!3/4  4/44/4 2/4  7.80  3~ 
4/4  3/44/4 4/4  >8.40 
4/44/4 4/4  4/41/4 1/4  6.84  31~ 
4/4 4/4 4/4 3/4  O/4  9. 
0/40/4 ~/4  0/40/4 {)/4  2.50  lOO,O0( 
+/4  3/4 1/4 {)/4  6.50  R 
++/4 4/41/4 {)/4  6.67 
3/41/4  3/40/4 {)/4  5.00  31( 
4/4 2/4 2/4 0/4  7.50 
D/40/41/4 2/4  0/40/4  1.88  131,90( 
1/4 2/4 3/4  3/4 0/4 {)/4  5.00  10( 
4/4 4/4i4/4  4/41/4 {)/40/4  6.67 
3/4 3/4 4/4 2/4  2/4 1/4 ~)/4  5.23  5~ 
4/4 4/4  4/4 2/4 {)/4 0/4  7.00 
4/43/43/4 3/4  4/42/4  6.4o  " 
2/2 4/4  2/4 2/4 {)/4  6.50 
4/4  4/4 1/4 1/4  6.84 
4/4 4/4 3/4  2/4 2/4 {)/4  6.30 
4/4 2/4 1/4 0/4  7.23 
4/4 Z/4  2/4 2/4 {)/4  6.00  10( 
4/4  2/4 3/413/4  7.70 
4/4  4/4 4/4 3/4 1/4  8.50  --~ 
4/4 4/4  3/4 3/4 2/4  7.57 
4/4 4/4 2/4 0/4  8.00 
* 3/3 ---- 3 of 3 mice injected died of W.E.E. 
antibodies.  Mice in the 10  -s group showed some neutralizing antibodies by the intra- 
peritoneal test---a neutralization index (N.I.) of 3,163. 
9th Day Test.--Group I mice (10  -8) showed good resistance, i.e., a resistance index 452  VACCINATION  IN  ENCEPHALITIS  IN~E~IONS 
TABLE H 
Neutralizing  Level of Seva from Mice Following Vaccination with W.E.E.  Virus 
*~mc 
after  Groups of 
vacclna-  mlce 
tion 
du~s 
10-t 
10-s 
10-7 
3  Formolized 
vaccine 
Controls 
101 
10-o 
I0-7 
9  Formolized 
vaccine 
Contruls 
10"* 
10-6 
I0-~ 
16  Formolized 
Controls 
101 
10-s 
10-~ 
3O  Formol~ed 
vaccine 
Controls 
lOS 
1oe 
10-~ 
58  Formolized 
vaccine 
Controls 
I0-* 
10-o 
10-7 
121  Formollzed 
vaccine 
Controls 
Degree of protection afforded by  Mortality of mice injected with mixtures of serum and virus  serum of vaccinated mice 
By intra-  By intrzperitoneal  Intracerebral test  Intraperitoneal test  cerebral test  test 
Dilution of virus  50 per  Neu-  50 per  in mixture  Dilution of virus in mixture  traliza-  cent  cent  Neutmli- 
lethal  t/on  lethal  ration indel 
10-4 I0~  tOe 10-7 10s 10g I0  -2 10-s  10-4 [0  ~  Ioe i0  -7  I0  "~ 10g I0  -t0  dose  index  dose 
I 
3/3  0/3  0/3  0/2  0/2  0/2  0/2  0/~  6.50  18  <3.50  3163-b 
3/3  3/3  3/3  2/2  2/2  2/2  2/2  8.50  --6  8.50  --32 
3/~  2/3  2/3  1/2  2/2  1/2  8.00  --2  7,60  --4 
3/3  2/3  0/3  1/~  1/2  0/2  1/2  7.25  3  6.00  10 
3/~  3/3  1/3  0/3  2/2  1/2  0/2  7.75  7.00 
w[ 
3/3  3/3  1/3  0/3  0/3  0/21  0/2  012  0/2  5.75  1000  <1.501  3,163,000+ 
3/3  3/3  0/3  0/3  0/3  0/2  0/2  0/2  0/2  0/2  0/2  5.50  1779  <1.50  3,163,000-1- 
3/3  3/3  3/3  3/3  3/3  0/3  2/2  2/2  2/2  2/2  2/2  1/2  8.50  1  8.00  1 
3/3  2/3  1/3  0/3  0/3  0/3  0/2  0/2  0/2  0/2  0/2  5.50  1779  <1.50  3,163,000.l- 
3/3  3/3  3/3  3/3  1/3  I  2/2  2/2  2/2  1/2  0/2  8.75  S.0( 
3/3  3/3  1/~  0/3  0/3  0/2  0/2  0/2  0/2  0/2  5.75  562  <1.50 I0,000,000-{- 
3/3  3/3  1/~  0/3  0/3  1/2  0/2  0/2 0/~  0/2  5.75  562  2.00  3,163,000 
3/3 3/~  0/3  0/3  0/2  0/2  0/2  0/2  0/2  0/2  6.50  100  <2.501  1,000,000-{- 
3/3  3/3  2/3  0/3  0/3  1/2  0/2  0/2  0/2  0/2  6.25  178  2.00  3,163,000 
313  3/3  3/3  0/3  2/2  2/2  2/2  212  0/2  8.50 
3/3  3/3  0/3  0/3  0/3  0/2  0/2  0/2  0/2  0/2  5.50 
8.50 
1000  <1.5(  10,000,000+ 
3/3  3/3  1/3  0/3  0/3  0/2  0/2  0/2  0/2  0/2  0/2  5.75  562  <1.5(  10,000,000-{- 
3/3  3/3  3/~  3/3  3/3  1/3  2/2  2/2  2/2  2/2  2/2  2/2  2/2  8.75  --2  8.5(  1 
5/3  3/3  0/3  0/3  0/5  0/2  0/2  0/2  0/2  0/2  0/2  0/2  5.50  1000  <1.5(  lO,O00,O00-l. 
I  2/2  3/3  3/~  3/3  3/3  0/3  2/2  2/2  2/2  0/2  8.50  8.5( 
3/5  3/3  1/3  0/3  0/3  0/2  012  0/2  0/2  0/2  0/2  5.75  5624  <1.5(  316,300+ 
3/3  3/3  3/3  3/3  0/3  1/2  0/2  0/2  0/2  0/2  0/2  ~  7.50  100  2.0C  100,000 
3/3  3/3  3/3  3/3  3/3  2/2  2/2  2/2  2/2  2/2  2/2  0/2  >8.50  <10  7.5(  --3 
5/3  5/3  2/3  0/3  0/3  0/2  0/2  0/2  0/2  0/2  0/2  6.25  1779  <1.5(  316,300-{- 
3/3! 5/3  3/3  3/3  3/3  2/2  1/21 1/2  2/2  0/2  9.50  7.0( 
~  i-  <1.50  3/3  2/3  I/3  0/3  0/3  0/2  0/2  0/2  0/2  0/2  0/2  5.50  562  3,t63,000+ 
3/3  3/3  1/3  0/3  0/3  0/2  0/2  0/2  0/~  0/2  0/2  5.75  316  <1.50! 3,163,000+ 
3/3  3/3  3/3  3/3  1/3  1/3  2/2  2/21 2/2  2/2  2/2  8.00  2  8.50  --3 
3/3  3/3  2/.  ~  0/3  0/3  0/3  0/2  0/2  0/2  0/2  0/2  0/2  6.25  100  1.50  3,163.000-}- 
I  :  3/3  3/~  3/3  2/3  o/~  2/2  2/2  2/2  2/2  1/2/0/2  8.23  s.~  1  t 
(R.I.) of 3,468, good neutralizing antibodies both intracerebrally  and intraperitoneally, 
with N.I. of 1,000 and 3,163,000  respectively.  The titer of comp|ement-fixing anti- 
bodies was high, 1:8 considering that this was not a hyperlmmune serum.  In group 
II (10-5), the amount of resistance was doubtful, with a R.I. of 35.  Yet neutralizing j.  CASALS  453 
antibodies were as high as in the preceding group, namely, N.I. of 1,779 on intmcere- 
bral test and 3,163,000 on intraperitoneal test.  Complement-fixing antibodies were 
present in very low titer, only the undiluted serum giving a  partial reaction.  In 
group HI (10-0, all tests were negative.  In group IV, treated with formolized vac- 
cine, the degree of resistance was low, with a R.I. of 316.  This group did not show as 
TABLE  Ill 
Summary  of Protection  Tests, Neutrabi~ation Tests, and Complement-Fixation Tesis 
u.,ilk  W.E.E.  Virus 
Treatment of mice 
0.5 cc. active virus, 
10-I subcutaneously 
0.5  cc. active virus, 
10"-i subcutaneously 
0.5  cc. active virus, 
t0-T subcutaneously 
Time after vaccination--days: 
Test 
3  9  16  30  58  121 
Resistance: protection index  2  3,465  100,000  131,900  7  I00 
Neutralization  (icer.):  neu-  18  1,00~  562  1,000  5,624  562 
tralizing index 
Neutralization  (iper.):  neu-  3,163 3,163,00¢  t0,000,000 10,000,000 316,300+  3,163,000 
O  1:8 
tralizing index 
Complement-fixation:  titer oi 
seruiI1 
Resistance: protection index  3~ 
Neutralization  (icer.):  neu-  --~  1,77~ 
tralizlng index 
Neutralization  (iper.)  neu-  --32 3,163,00¢ 
tralizlng index 
Complement-fixation:  titer o]  C  1:I 
seruin 
Resistance: protection index 
Neutralization  (icer.):  neu-  --2 
tralizing index 
Neutralization  (iper.):  neu-  --4 
tralizlng index 
Complement-fixatlon: titer oi  C 
serunl 
¢ 
31~ 
,~  1,77~ 
1C !3,163,00( 
(]  1:4 
Resistance: protection index 
Neutralization  (icer.):  hen- 
0.2  cc.  formolized  tralizing index 
vaccine X 3 subcu-  Neutralization  (iper.):  neu- 
taneously  [  tralizing index 
J 
Complement-fixation:  titer ot 
sertlrft 
1:8  1:8  1:8  1:16 
10  100  .5  2 
.562  .562  100  316 
3,163,000  10,000,000  100,000  3,163,000 
1:8  1:8  1:8  1:8 
?  2  2  --3 
100  --2  10  2 
1,000,0~  1  --3  --3 
0  0  0  0 
316  59  8  3 
178  1,000  1,779  100 
3,163,000 10,000,000 316,300  3,163,000 
1:8  1:8  1:8  1:8 
high a degree of resistance as was anticipated in view of the experience of other workers 
and it remained low during the entire experiment.  Yet, the values obtained were well 
within the significant range.  On the other hand, the neutralizing antibodies in this 
group were very high, with a N.I. of 1,779 on intracerebral test and 3,163,000 on in- 
traperitoneal test.  Complement-fixing antibodies were present in fair titer in a dilu- 
tion of 1:4.  This is noteworthy because of the short time that elapsed between time 
of vaccination and bleeding for test, and also because the material used for vaccination 
was avirulent. 
16th Day Test.--In group I (10  -a), resistance to intmcerebral infection was very high, 454  VACCINATION IN ENCEPHALITIS INFECTIONS 
with a R.I. of 100,000.  Neutralizingantibodies remainedat approximately thesame 
level as in the 9th day test, showing a N.I. of 562 for the intracerebral test and 10,000- 
000 for the intraperitoneal test.  Complement-fixing antibodies had a  titer of 1:8. 
In Group II (10-5), immunity was either absent or negligible, with a R.I. of 10, whereas 
the neutralizing antibodies showed a level as high as that of the preceding group, that 
is, a N.I. of 562 on intracerebral test and 3,163,000  on intraperitoneal test.  The titer 
of complement-fixing antibodies rose to 1:8.  In group III (10-7), there was no im- 
munity.  The neutralizing antibodies were positive to the extent of a N.I. of 100 on 
intracerebral test and 1,000,000  on intraperitoneal test.  Probably not much signifi- 
cance should be attached to these figures for neutralizing antibodies since this was the 
only positive reaction shown at any time by this group.  It might be that the develop- 
ment of antibodies in an individual  mouse made this particular batch of serum positive. 
Complement-fixing antibodies were recorded as negative, although a plus-minus reac- 
tion occurred in the tube containing undiluted serum.  In group IV, treated with for- 
molized vaccine, a  significant though low  resistance was demonstrated, with a  R.I. 
of 316; by intracerebral test neutralizing antibodies were slightly lower than in groups 
I and II and there was a N.I. of 178.  On intraperitoneal test the level was again 3,163- 
000; the titer of complement-fixing antibodies was 1:8. 
30th Day Test.--Group  I (10  -~) mice showed good resistance, with a R.I. of 131,900; 
neutralizing antibodies had a level of 1,000 (N.I.) by intracerebral test, and 10,000,000 
by intraperitoneal test.  The titer of complement-fixing antibodies was 1:8.  Mice 
in group II (10  -5) showed a mild resistance, with a R.I. of 100.  Neutralizing anti- 
bodies showed a good level, i.e., 562 N.I. on intracerebral test and 10,000,000  on intra- 
peritoneal test.  The titer of complement-fixing antibodies was again 1:8.  In group 
III (10-7), resistance, neutralizing and complement-fixing antibodies were all negative. 
In group IV, treated with formolized vaccine, the amount of resistance was barely 
significant, with a R.I. of 59.  On  the contrary, neutralizing antibodies were high, 
with a  N.I.  of 1,000  on  intracerebral test and  10,000,000  on intraperitoneal test; 
the complement-fixing antibodies were also high, with a titer of 1:8. 
58thDay Test.--In group I (10-a), resistance to infection was negative, but neutraliz- 
ing antibodies by both intracerebral and intraperitoneal test remained high, with N.I. 
Of 5,624  and 316,300  plus respectively.  The  titer of complement-fixing antibodies 
remained unchanged,  1:8.  In group II (10-s), no resistance was detected.  On in- 
tracerebral test neutralizing antibodies had a level of 100 (N.I.) and on intraperitoneal 
test the N.I. was  100,000.  The titer of the complement-fixing antibodies was 1:8. 
In group III (10-~), all results were negative.  In group IV, treated with formolized 
vaccine, resistance to intracerebral infection was negative; neutralizing antibodies were 
positive with a level of 1,779 (N.I.) by intracerebral test, and 316,300 by intraperitoneal 
test.  The titer of complement-fixing antibodies was 1:8. 
121st Day Test.--In group I  (10  -3) the amount of resistance in this last test was 
found to be 100 (R.I.).  Neutralizing antibodies were at about the same level as they 
had been in most of the other tests, that is, 562 (N.I.) by intracerebral test and 3,163- 
000 by intraperitoneal test.  The titer of complement-fixing antibodies did not show 
any tendency to fall off at this stage, remaining at 1 : 16.  In group II (10  -6) resistance 
to infection was negative.  The level of neutralizing antibodies was 316  (N.I.)  by 
intracerebral test and 3,163,000  by intraperitoneal test.  The titer of complement-fix- J.  CASALS  455 
ing antibodies was 1:8.  In group III (10-'), all results were again negative.  In group 
IV (formolized vaccine), no resistance was present.  Neutralizing antibodies by in- 
tracerebral test had the lowest level except in the test on the 3rd day, when the N.I. 
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FzG.  1.  Correlation between  resistance to infection, complement-fixing and  neu- 
tralizing antibodies in mice vaccinated with W.E.E. virus.  C.F.  =  titer of comple- 
meat-fixing  antibodies.  R.I.  (resistance  index)  =  degree  of  resistance  (~.I..D.) 
shown  by mice infected intracerebrally.  N.I.  (neutralization index)  =  degree of 
protection (M.L.D.) given by the immune sera.  -3,  -5,  -7, and Formalin indicate 
the four different groups of vaccinated mice included in the experiment. 
was 100.  Tested intraperitoneally the levd was 3,163,000.  Complemeat-fi~ing anti- 
bodies were present to a  titer of 1:8. 
The results of this experiment are presented graphically in Fig.  1 and will 
be discussed together with those of the next experiment. 
The second experiment was designed along the lines of the first--this time 
with St. Louis encephalitis virus--to compare at various intervals over a period 456  VACCINATION  IN ENCEPHALITIS  INFECTIONS 
of 9 months the immunity, and neutralizing and complement-fixing antibodies 
in mice following vaccination with virulent or non-virulent virus. 
Experiment  2.--740 W-Swiss mice, 60 to 75 days of age and weighing from 20 to 
24 gm. at the beginning of the experiment, were employed.  These mice were divided 
into four groups and  treated as  follows.  Group I, 196 mice, were given one subcu- 
taneous injection of 0.5 cc. of live  virus in a dilution of 10-~; group II, 193 mice, received 
one injection of live virus subcutaneously, 0.5 cc. in a dilution of 10-4; group III, 199 
mice, received one subcutaneous injection of 0.25 cc. of a 10 per cent formolized aviru- 
lent St. Louis vaccine daily, for 4 consecutive days, the total amount of vaccine given 
being then  1 cc.  Finally, group IV, 152 mice, were set aside as untreated controls. 
Following vaccination no mice died in any of the different groups.  At intervals 
after vaccination mice selected from each group were tested  for resistance by intra- 
cerebral injection of St. Louis virus and bled so that their sera might be tested for 
neutralizing and complement-fixing antibodies.  Tests were carried out on the follow- 
ing days from the beginning of  the experiment: 3,  7,  14, 31,  59,  91, 203,  and 266. 
The detailed results are given in Tables IV, V, and VI. 
3rd Day Test.--None of the mice had developed any resistance, neutralizing or 
complement-fixing antibodies by the 3rd day. 
7th Day Test.--Mice in group I  (10 -2) showed a low but definite resistance, with a 
R.I. of 145.  Neutralizing antibodies were negative and complement-fixing antibodies 
positive, with a  titer of 1:4.  Mice in group II (10  -4) had developed no resistance, 
neutralizing or complement-fixing antibodies.  Mice in  group  III (formolized vac- 
cine) had no resistance or neutralizing antibodies; the complement-fixing antibodies 
were recorded as negative, although a  partial fixation occurred with the undiluted 
serum. 
14th Day Test--Mice in group I  (10 -~) had a high degree of resistance with an index 
of  1,000,000.  On  the other hand,  neutralizing antibodies were negative since the 
N.I. was 7 or less.  The complement-fixing antibodies had a titer of 1:2.  Group II 
(10-9 showed no significant resistance or neutralizing antibodies, but some comple- 
ment-fixing antibodies were present to a titer of 1 : 1.  The group with the formolized 
vaccine was negative in all tests. 
31st Day Test.--Mice in the 10  -2 group still showed high resistance with an index 
of  426,000.  The  level of  neutralizing antibodies remained  unchanged  and  below 
significant  value;  the  titer  of  complement-fixing antibodies  was  1:4.  Group  II 
(10-9  had developed complement-fixing antibodies in a  titer of 1:2 but neither re- 
sistance nor neutralizing antibodies.  The formolized vaccine group had developed 
complement-fixing antibodies in  fair titer  (1:4)  but  no  resistance or neutralizing 
antibodies by this time. 
59th Day Test.--The resistance shown by the mice in the 10-' group was very low 
and barely significant (R.I. of 45).  Neutralizing antibodies which in previous tests 
had remained below a N.I. of 10 now acquired a level of 46 N.I., which, although within 
the doubtful range, was the highest yet obtained in this group.  This neutralization 
test was repeated and then it gave a  N.I. of 129 which must be regarded as definitely 
positive.  The  titer of complement-fixing antibodies rose  to  1:16.  This  test was 
also repeated and the same titer (1 : 16) was obtained a second time.  Group II (10-  9 j.  CASALS  457 
TABLE IV 
Immunity ~  I~r~ebr~ Inoculati~  ~  ~.Lou~ E~hal~V@~  Following Vacclmztlon 
Time after 
vaccina- 
tion 
days 
3 
14 
31 
59 
91 
203 
266 
Groul~ of mice 
10-~ 
10-4 
Formolized vaccine 
Controls 
lO s 
10-~ 
Formolized vaccine 
Controls 
10  ~ 
10-4 
Formolized vaccine 
Controls 
10-2 
10-4 
Formolized vaccine 
Controls 
10-2 
10-4 
Formolized vaccine 
Controls 
10  ~ 
10-4 
Formolized vaccine 
Controls 
10-* 
10-~ 
Formolized vaccine 
Controls 
10-~ 
10-4 
Formolized vaccine 
Controls 
Mortality of mice injected intr&cere- 
braliy with St. Louis encephalitis 
virus 
Degree of immunity 
of vaccinated mice 
Dilution of virus injected 
intracerebrally  50 per cent  lethal  Protection 
I0-~]10-'  [0-~[ 10-s  10-e 10-'  101 10-t  dose  index 
3/3* 3/3 2/3 0/3  7.25  2 
3/3  3/3 1/30/3  6.75  6 
3/3  3/3 2/30/3  7.25  2 
3/3  3/3 2/3 1/3  7.50 
4/4 2/4 2/4 2/4  3/4 2/4  5.34  145 
4/4 3/4 ~/4 3/4  4/4 2/4  6.60  8 
~/4 4/4  4/4 ~/4 1/4  7.67  --1 
4/4  4/4 t/40/40/4  7.50 
0/40/4 1/40/4  2/4 1/4  2.00  1,000,000 
4/4 ~/4 4/4  4/4 2/4  7.00  10 
~/44/4  4/4 ~/4  7.50  3 
4/4  4/4 ~/42/40/4  8.00 
3/40/4 1/40/4  2/4 1/4  2.87  426,600 
~/4 4/4  4/4 1/4 0/4  7.50  10 
1/4 4/4  4/4 i/4 1/3  7.75  6 
4/4  4/4 ~/44/40/4  8.50 
4/42/4 3/43/4  2/4 1/41/40/4  5.58  45 
~/4¢/4  4/4 1/40/40/4  6.67  4 
~/44/4  4/4 2/40/40/4  7.00  2 
4/4  4/4 2/4 1/40/4  7.23 
3/4 1/4 1/4  3/4 l/4  4.53  501 
4/4 ~/4 3/4  2/4 ~/4 0/4  5.77  29 
4/4 ~/44/4  4/4 2/40/4  7.00  2 
4/4  4/4 2/4 1/4 0/4  7.23 
4/4 ~/4 4/4  3/4 z/4 0/4  6.77  4 
4/4 ~/4 4/4  3/4 ~/4 0/4  7.38  -  1 
4/4 ~/4 4/4  4/4 ~/4 1/4  7.67  --2 
~/4 ~/4  4/4 3/4 0/4 0/4  7.34 
3/4 4/4  2/4 0/4  6.56  28 
4/44/4  4/4 3/411/4  [  7.50  3 
4/44/4  4/4 3/4]0/4[  7.34  5 
I  14/4 4/4 ~/412/4]0/4  8.00 
* 3/3 ---- 3 of 3 mice injected died of St. Louis encephalitis. 458  VACCINATION IN ENCEPHALITIS INFECTIONS 
TABLE  V 
Neutralizing Level of Sera  from M~ce Following Vaccination ~ith St. Louis F.,ncephalills Vir~ 
Time 
after 
vacci- 
nation 
days 
3 
14 
31 
59 
91 
203 
266 
Groups of mice 
10--* 
10-* 
Formolized vaccine 
Controls 
lO-S 
10-* 
Formolized vaccine 
Controls 
10t 
10-4 
Formolizcd  vaccine 
Controls 
10-2 
10  ~ 
Formolized vaccine 
Controls 
lO-S 
10-* 
Formolized vaccine 
Controls 
10-2 
10-4 
Formolized vaccine 
Controls 
10--2 
10-4 
Formolized vaccine 
Controls 
10-2 
10-* 
Formolized vaccine 
Controls 
Mortality of mice injected intracerebrally Degree  of  protectinn  afforded by serum  with mixtures of serum and virus  of vaccinated  mice 
Dilution of virus in mixture  !50 per cent Neutral- 
lethal  ization 
10"t  10~  10-~  10-e  1O  ~  10s  10-*  dose  index 
4/4  4/4  4/4  1/4  0/4  5.67  4 
4/4  4/4  4/4  1/4  0/4  5.67  4 
4/4  4/4  4/4  2/4  1/4  6.23  1 
4/4  4/4  2/4  1/3  0/4  6.25 
4/4  4/4  3/4  0/4  0/4  5.34  1 
4/4  4/4  4/4  0/4  0/4  5.50  1 
4/4  4/4  3/4  0/4  0/4  5.34  1 
4/4  4/4  0/4  0/4  0/4  5.50 
4/4  4/4  4/4  4/4  >6.50  <7 
4/4  4/4  4/4  4/4  >6.50  <7 
4/4  4/4  4/4  4/4  >6.50  <7 
4/4  4/4! 4/4  3/4  0/4  7.34 
4/4  4/4  4/4i 4/4  >6.50  <7 
4/4  4/4  4/4  i 4/4  >6.50  •7 
4/4  4/4  4/4  4/4  >6.50  <7 
4/4  4/4  4/4  3/4  0/4  7.34 
4/4  4/4  3/4  0/4  0/4  0/4  5.34 
4/4  4/4  4/4  2/4  0/4  1/4  6.22 
4/4  4/4  4/4  3/4  0/4  0/4  6.34 
4/4  4/4  4/4  2/4  0/4  0/4  7.00 
4/4  4/4  4/4  1/4  0/4  0/4  5.67 
4/4  4/4  4/4  3/4  0/4  0/4  6.34 
4/4  4/4  4/4  4/4  0/4  1/4  6.57 
4/4  4/4  3/4  3/4  0/4  0/4  7.17 
4/4  4/4  4/4  4/4  1/4  0/4  6.67 
4/4  4/4  4/4  3/4  0/4  0/4  6.34 
4/4  4/4  3/4  2/4  0/4  0/4  5.77 
4/4  4/4  4/4  3/4  0/4  0/4  7.34 
46 
6 
5 
32 
7 
4 
5 
10 
37 
4/4  4/4  3/4  2/4  o/4  6.77  8 
4/4  4/4  4/4  o/4  2/4  6.75  8 
4/4  4/4  3/4  2/4  o/4  6.77  8 
4/4  4/4  1/4  0/4  7.67 J.  CASALS  459 
did not reveal any significant resistance or neutralizing antibodies, while the titer of 
complement-fixing antibodies was  1:8.  The  formolized  vaccine group  had  no re- 
sistance or neutralizing antibodies but complement-fixing antibodies were  positive, 
with a titer of 1 : 16. 
91st Day Test.--Group I  (10  -~) :  Although the R.I. was higher than in the preceding 
test (501), yet this degree of resistance could not be considered as very high.  Neu- 
tralizing antibodies in the blood were low, with a  level of 32 which places it in the 
doubtful  range.  The  titer  of  complement-fixing antibodies  was  1:8.  Group  II 
TABLE VI 
Summary of Protection Tests, Neutralization Tests, and Complement-Fixation Tests witk 
St. Louis Encephalitis Virus 
Treatment of mice 
0.5 cc. active 
virus, I0  -~ sub- 
cutaneously 
0.5 cc. active 
virus, 10  -~ sub- 
cutaneously 
0.25 ce. formol- 
lized vaccine 
X  4 subcu- 
taneously 
Test 
Time after vaccination----days: 
7  14  31  59  91  203  266 
Resistance:  protection  1451,000,000426,000  45  501  4  28 
index 
Neutralization:  neu-  1  <7  <7  46  32  5  8 
tralizing index 
Complement-fixation:  1:4  1:2  1:4  1:16  1:8  1:2  .:16 
titer of serum 
Resistance: protection  8  10  10  4  29  -- 1  3 
index 
Neutralization: neu-  1  <7  <7  6  7  10  8 
tralizing index 
Complement-fixation:  0  1:1  1:2  1:8  1:8  0  1:4 
fiter of serum 
Resistance: protection 
index 
Neutralization: neu- 
tralizing index 
Complement-fixation: 
titer of serum 
-1  3  6  2  2  -2  5 
1  <7  <7  5  4  37  8 
1:1?  0  1:4  1:16  1:4  0  1:4 
(10  -4)  mice  showed  a  doubtful resistance  to  intracerebral infection  (R.I.  of  29). 
Neutralizing antibodies were  negative  and  complement-fixing antibodies  positive, 
with a  titer of 1:8.  The formolized vaccine group was negative for resistance and 
neutralizing antibodies; the complement-fixing antibody titer was 1:4. 
203rd Day  Test.--In  the  10-* group  resistance and neutralizing antibodies were 
negative, while the complement-fixing antibodies had a low titer (1:2).  In the 10  -* 
group resistance and antibodies were negative.  In the formolized vaccine group, the 
level of neutralizing antibodies was doubtful (N.I. 37); resistance and complement- 
fixing  antibodies  were  negative. 
266th  Day Test.--Resis~nce  to infection and neutralizing antibodies were either 
negligible or negative in all groups.  On the other hand, complement-fixing  antibodies 460  VACCINATION IN ENCEPHALITIS IN]~ECTIONS 
were still present in each group.  In mice of the 10-' group the titer was particularly 
high,  1 : 16. 
Fig. 2 presents  a graphic summary of the experiment  with St. Louis encephalitis 
virus. 
The  results  of  both  experiments  may  be summarized  as  follows.  In  the 
test with W.E.E. virus, the three groups of mice injected subcutaneously with 
the large and the intermediate doses of live virus, and the formolized vaccine, 
C.E R.I, 
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FIG. 2. Correlation between resistance  to infection,  complement-fixing  and neu- 
tralizing  antibodies  in  mice  vaccinated  with St.  Louis  encephalitis  virus. C.F.,  R.I., 
N.I.,  the  same  as  in  Fig.  I.  -2, -4,  and  Formalin  indicate  the  three  different  groups 
of vaccinated mice included in the experiment. 
all showed the same general relationship between intracerebral resistance and 
antibodies.  Of mice receiving the live virus, 20 per cent died, in contrast to 
none among those receiving the formolized vaccine.  Intracerebral resistance 
developed within 9 to 16 days and reached a maximum by 30 days.  The titer 
of intracerebral resistance was highest in mice receiving the greatest amount of 
virulent virus, next in those receiving formolized vaccine, and least in those re- 
ceiving the moderate dose of live virus.  Intracerebral resistance in the three 
groups of mice decreased sharply within 58 days.  Neutralizing antibodies be- 
haved alike in all three groups.  They reached a  similarly high maximum level 
as soon as or sooner than intracerebral resistance and persisted undiminished J.  CASALS  461 
throughout the 4 month period of  the experiment.  Complement-fixing anti- 
bodies developed and persisted in like manner except that their time of develop- 
ment seemed to parallel resistance slightly more closely than that of neutral- 
izing antibodies.  On the other hand, mice injected subcutaneously with the 
smallest dose of live virus, 10  -7 dilution, fatal to 0.7 per cent, developed little 
if  any resistance.  Neutralizing antibodies were detected at 16 days but  not 
thereafter, and complement-fixing antibodies remained negative. 
In short, we find in this experiment a  fair, qualitative parallelism between 
intracerebral  resistance and antibodies, with  numerous slight, but generally 
consistent discrepancies.  Thus, (1)  neutralizing antibodies appear and reach 
maximum level sooner than resistance.  (2)  This maximum level of neutralizing 
antibodies is approximately the same, regardless of whether intracerebral resis- 
tance is high, medium, or low.  (3)  Neutralizing antibodies persist relatively 
unchanged in high level over long periods of time while intracerebral resistance 
is decreasing and even when it is no longer detectable.  (4)  Neutralizing anti- 
bodies may be found in instances in which the dose of virus has been too small 
to produce resistance.  Complement-fixing antibodies, on the other hand, tend 
to appear somewhat more in conjunction with resistance but, once present, last 
much longer. 
In the test with St. Louis encephalitis virus, mice injected subcutaneously 
with the large dose of virus, 10  -~ dilution, remained well and developed high 
intracerebral resistance which reached a maximum at 14 days, declined sharply 
at 59 days, remained at this low level at 91 days, but became negligible at 203 
and 266  days.  Neutralizing antibodies first appeared  in significant level at 
59 days, when resistance showed its initial sharp drop.  They remained at this 
same approximate level at 91 days but became negligible thereafter.  Comple- 
ment-fixing antibodies developed with resistance but did not reach maximum 
titer before 59 days, at which time resistance had decreased.  They persisted at 
high levels throughout the 266 days of the experiment.  The groups of mice 
injected subcutaneously with the small dose of virulent virus, 10  -~ dilution, or 
with the formolized vaccine, remained well and reacted in the same general 
manner.  No significant resistance developed at any time during the experi- 
ment, nor did neutralizing antibodies appear in significant titer.  Complement- 
fixing antibodies, however, developed and persisted in about the same manner 
as in the first group, although at a  slightly lower level.  In short, little cor- 
relation was found in this experiment between resistance and antibody forma- 
tion.  Neutralizing antibodies appeared only in mice which had developed re- 
sistance but in them not until resistance had begun to decrease.  Their level 
was  low  and  their duration  varied.  Complement-fixing antibodies,  on  the 
other hand,  developed regularly and persisted  at  high levels in all  groups, 
whether or not resistance was demonstrable. 462  VACCINATION IN ENCEPHALITIS  INFECTIONS 
DISCUSSION 
The trend of the data presented here differs but little from that of those al- 
ready published (4,  8).  Our finding of maximum levels of neutralizing anti- 
bodies in spite of different titers of intracerebral resistance should, perhaps, have 
been scrutinized further by testing diluted sera according to the procedure of 
Schlesinger, Morgan, and Olitsky (9).  Still, the fact remains that antibodies 
persisted after resistance became negligible and antibodies appeared in instances 
in which intracerebral resistance was entirely lacking, as Morgan already had 
found with E. E. E. virus  (10).  Results of the experiments with St. Louis 
encephalitis virus differed quantitatively from previous results (8) in that more 
virus was required to produce resistance and antibodies appeared less readily 
after 12 weeks, and the phenomenon of falling resistance in the face of rising 
antibodies,  though present,  was less pronounced.  This difference, we have 
reason to believe, is due to the present use of virus with a history of many intra- 
cerebral mouse passages rather than of freshly isolated strains (11).  All in all, 
we believe that these and other reported experiments fail to warrant the as- 
sumption that if antibodies are found, intracerebral resistance must be pres- 
ent too. 
Now if the slightest uncertainty obtains in these mouse tests as to the reli- 
ability of antibodies--neutralizing or complement-fixing---as an index of im- 
munity, it becomes advisable, in our opinion, to be cautious in applying the 
antibody test---carried out with undiluted sera--as a criterion of resistance fol- 
lowing vaccination of populations in the field.  The mouse tests, though well 
controlled, are  artificial: such studies would be  of greater value if made  in 
a  more natural host under  similar controlled conditions.  Moreover,  in the 
mouse  experiments,  the  highly artificial intracerebral  portal  of  entry  was 
necessary, but  in  a  more  suitable  experiment with a  natural  host,  a  more 
natural route might perhaps be used.  In short, when faced with controlled 
though artificial experimental data which themselves are not convincing, one 
might well approach the problem of field testing of vaccines with caution and 
regard the presence of antibodies merely as evidence that some specific reaction 
has occurred, unless actual protection is proved. 
SUMMARY 
In mice vaccinated subcutaneously with different doses of virulent W.E.E. 
virus or with formolized vaccine, neutralizing and complement-fixing antibodies 
paralleled resistance to some extent yet appeared in groups in which resistance 
remained undetectable, persisted at a similar maximum level in spite of different 
titers of resistance, and after resistance had become negligible. 
In mice vaccinated subcutaneously with different doses of virulent St. Louis 
encephalitis virus or with formolized vaccine, neutralizing and complement- j.  CASALS  463 
fixing  antibodies  bore  little  relation  to  resistance.  Neutralizing  antibodies 
appeared  only in  the group  showing resistance  but not  until  resistance  was 
diminishing.  Complement-fixing antibodies developed equally well in groups 
with or without resistance. 
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